[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Endres et al., 2009 - Google Patents

Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo

Endres et al., 2009

Document ID
4819692621364992924
Author
Endres K
Mitteregger G
Kojro E
Kretzschmar H
Fahrenholz F
Publication year
Publication venue
Neurobiology of disease

External Links

Snippet

Both the cellular prion protein (PrPc) and the amyloid precursor protein (APP) are physiologically subjected to complex proteolytic processing events. While for APP the proteinases involved–alpha-, beta-and gamma-secretase–have been identified in vitro and …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein

Similar Documents

Publication Publication Date Title
Endres et al. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo
George et al. Decreased phosphatidylethanolamine binding protein expression correlates with Aβ accumulation in the Tg2576 mouse model of Alzheimer's disease
Bu et al. LRP in Amyloid‐β Production and Metabolism
Grimm et al. Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer’s disease
Aso et al. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer's disease
Smit et al. Reactive astrocytes as treatment targets in Alzheimer's disease—systematic review of studies using the APPswePS1dE9 mouse model
Muntané et al. α-synuclein phosphorylation and truncation are normal events in the adult human brain
Gauthier et al. Protective mechanisms by cystatin C in neurodegenerative diseases
Malnar et al. Bidirectional links between Alzheimer's disease and Niemann–Pick type C disease
Kim et al. Lysosomal proteases are involved in generation of N-terminal huntingtin fragments
He et al. Effects of α-synuclein-associated post-translational modifications in Parkinson’s disease
Kulic et al. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation
Wong et al. Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology
Satoh et al. TMEM106B expression is reduced in Alzheimer’s disease brains
Avila‐Muñoz et al. Cholesterol‐induced astrocyte activation is associated with increased amyloid precursor protein expression and processing
Arif et al. Effects of memantine on soluble Αβ25-35-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions
O’Keefe et al. Using Drosophila models of amyloid toxicity to study autophagy in the pathogenesis of Alzheimer’s disease
Hashimoto et al. Neuronal glutathione loss leads to neurodegeneration involving gasdermin activation
Afram et al. The η-secretase-derived APP fragment ηCTF is localized in Golgi, endosomes and extracellular vesicles and contributes to Aβ production
Barker et al. Plasminogen and plasmin in Alzheimer's disease
Caccamo et al. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aβ oligomers accumulation
Silveyra et al. Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation
Walter γ-Secretase, apolipoprotein E and cellular cholesterol metabolism
Kuzuya et al. Presenilin 1 is involved in the maturation of β‐site amyloid precursor protein‐cleaving enzyme 1 (BACE1)
Ferreira et al. S327 phosphorylation of the presynaptic protein SEPTIN5 increases in the early stages of neurofibrillary pathology and alters the functionality of SEPTIN5